Discover how hybrid vectors, lipopolyplexes, and virus-like particles overcome stability and targeting barriers for mRNA delivery in preclinical research. Introduction Messenger RNA (mRNA)-based therapeutics have transformed the landscape of vaccine development, geneRead More…